Search
Now showing items 1-10 of 79
Choice of study phenotype in osteoporosis genetic research
Chen, Yuan; Shen, Hui; Yang, Fang; Liu, Peng-Yuan; Tang, Nelson; Recker, Robert R.; Deng, Hong-Wen. Choice of study phenotype in osteoporosis genetic research. Journal of bone and mineral metabolism. 2009, MAR. 27(2):121-126.
Oral Ibandronate Preserves Trabecular Microarchitecture: Micro-Computed Tomography Findings From the Oral Ibandronate Osteoporosis Vertebral Fracture Trial in North America and Europe Study
Decker, Robert R.; Ste-Marie, Louis-Georges; Langdahl, Bente; Masanauskaite, Daiva; Ethgen, Dominique; Delmas, Pierre D. Oral Ibandronate Preserves Trabecular Microarchitecture: Micro-Computed Tomography Findings From the Oral Ibandronate Osteoporosis Vertebral Fracture Trial in North America and Europe Study. Journal of Clinical Densitometry. 2009, JAN-MAR. 12(1):71-76.
A polymorphism of apolipoprotein E (APOE) gene is associated with age at natural menopause in Caucasian females
He, Li-Na; Recker, Robert R.; Deng, Hong-Wen; Dvornyk, Volodymyr. A polymorphism of apolipoprotein E (APOE) gene is associated with age at natural menopause in Caucasian females. Maturitas. 2009, JAN 20. 62(1):37-41.
Kriterien zur sicherheit und wirksamkeit
Heaney, R. P. Kriterien zur sicherheit und wirksamkeit. Schweizer Zeitschrift für Ernährungsmedizin. 2009. 2:28-30.
Novel and Existing Mutations in the Tyrosine Kinase Domain of the Epidermal Growth Factor Receptor are Predictors of Optimal Resectability in Malignant Peritoneal Mesothelioma
Foster, Jason M.; Gatalica, Zoran; Lilleberg, Stan; Haynatzki, Gleb; Loggie, Brian W. Novel and Existing Mutations in the Tyrosine Kinase Domain of the Epidermal Growth Factor Receptor are Predictors of Optimal Resectability in Malignant Peritoneal Mesothelioma. Annals of Surgical Oncology. 2009, JAN. 16(1):152-158.
Does tibolone reduce the risk of fracture in older postmenopausal women with osteoporosis?
Gallagher, J. C. Does tibolone reduce the risk of fracture in older postmenopausal women with osteoporosis? Nature clinical practice.Endocrinology & metabolism. 2009, Jan 20. 5(3):128-129.
Optimal Vitamin D Status
Heaney, Robert P. Optimal Vitamin D Status. Journal of Bone and Mineral Research. 2009, APR. 24(4):755-755.
Preponderance of the evidence: an example from the issue of calcium intake and body composition
Heaney, R. P. and Rafferty, K. Preponderance of the evidence: an example from the issue of calcium intake and body composition. Nutrition reviews. 2009, Jan. 67(1):32-39.
Two year results in a randomized, double-blind, placebo-controlled study of odanacatib (MK-822) in postmenopausal women with low bone mineral density
Eisman, J. A.; Recker, R. R.; McClung, M.; Bone, H.; Roux, C.; Verbruggen, N.; Hustad, C. M.; DaSilva, C.; Santora, A.; Ince, A. Two year results in a randomized, double-blind, placebo-controlled study of odanacatib (MK-822) in postmenopausal women with low bone mineral density. Bone. 2009, 05/02. 44:S103-S104.
Insulin Glargine: a review 8 years after its introduction
Goykhman, Stanislav; Drincic, Andjela; Desmangles, Jean Claude; Rendell, Marc. Insulin Glargine: a review 8 years after its introduction. Expert opinion on pharmacotherapy. 2009, MAR. 10(4):705-718.